Colorectal Cancer Video Perspectives

In these videos, Howard S. Hochster, MD, FACP, associate director for clinical research and director of gastrointestinal oncology at Rutgers Cancer Institute, discusses:

• the benefits of targeting genomic alterations using gene analysis;
• the importance of identifying mutations — such as RAS, KRAS and BRAF — and how these and other factors such as location of tumors, can affect survival outcomes;
• how advances in treatments have improved survival outcomes for patients with metastatic colorectal cancer;
• how circulating tumor DNA could change the treatment and diagnosis of colon cancer and other unmet needs of patients;
• what's in the pipeline and how the development of drugs that can address KRAS drivers could transform the treatment landscape; and
• disparity issues in the diagnosis and treatment of colorectal cancer.